# Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine

> **NCT03599596** · PHASE1 · UNKNOWN · sponsor: **University College Hospital, Ibadan** · enrollment: 136 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Sulphadoxine-pyrimethamine
- **DRUG:** Sulphadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT03599596
- **Lead sponsor:** University College Hospital, Ibadan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03599596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03599596, "Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03599596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*